Critical stages of a biodetection platform development from sensor chip fabrication to surface chemistry and assay development

Yildiz Uludag

doi:10.1117/12.2051032

Translator Disclaimer

5 June 2014 Critical stages of a biodetection platform development from sensor chip fabrication to surface chemistry and assay development

Yildiz Uludag

Author Affiliations +

Proceedings Volume 9112, Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV; 911212 (2014) https://doi.org/10.1117/12.2051032
Event: SPIE Sensing Technology + Applications, 2014, Baltimore, Maryland, United States

Abstract

Once viewed solely as a tool to analyse biomolecular interactions, biosensors are gaining widespread interest for diagnostics, biological defense, environmental and quality assurance in agriculture/food industries. Advanced micro fabrication techniques have facilitated integration of microfluidics with sensing functionalities on the same chip making system automation more convenient1. Biosensor devices relying on lab-on-a-chip technologies and nanotechnology has attracted much of attention in recent years for biological defense research and development. However, compared with the numerous publications and patents available, the commercialization of biosensors technology has significantly lagged behind the research output. This paper reviews the reasons behind the slow commercialisation of biosensors with an insight to the critical stages of a biosensor development from the sensor chip fabrication to surface chemistry applications and nanotechnology applications in sensing with case studies. In addition, the paper includes the description of a new biodetection platform based on Real-time Electrochemical Profiling^TM (REP^TM) that comprises novel electrode arrays and nanoparticle based sensing. The performance of the REP^TM platform has been tested for the detection of Planktothrix agardhii, one of the toxic bloom-forming cyanobacteria, usually found in shallow fresh water sources that can be used for human consumption. The optimised REP^TM assay allowed the detection of P. agardhii DNA down to 6 pM. This study, showed the potential of REP^TM as a new biodetection platform for toxic bacteria and hence further studies will involve the development of a portable multi-analyte biosensor based on REP^TM technology for on-site testing.

Citation Download Citation

Yildiz Uludag "Critical stages of a biodetection platform development from sensor chip fabrication to surface chemistry and assay development", Proc. SPIE 9112, Sensing Technologies for Global Health, Military Medicine, and Environmental Monitoring IV, 911212 (5 June 2014); https://doi.org/10.1117/12.2051032

ACCESS THE FULL ARTICLE